Literature DB >> 7378013

Experimental combined systemic and local chemotherapy for intraocular malignancy.

H S Liu, M F Refojo, D M Albert.   

Abstract

Greene melanoma was transplanted into the anterior chamber of rabbit eyes. These animal models were divided into four groups. Group 1 received carmustine (1,3 bis [2-chloroethyl]-1-nitrosourea) intravenously. Group 2 received the drug by sub-Tenon-retrobulbar (periocular) injection. Group 3 received both periocular and intravenous administration; the combined dose was the same as that in group 1. Group 4 served as untreated control. The effectiveness of the various administration routes was compared by clinical observation of the size of the tumor growing in the eye, weight of the enucleated eyes, and histopathologic examination. Administration of carmustine delayed the growth of Greene melanoma in rabbit eye of all three treated groups, but effectiveness of treatment was considerably enhanced by combining periocular and intravenous administration of a lower dose of carmustine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378013     DOI: 10.1001/archopht.1980.01020030899019

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

Review 1.  Concise Review: Using Stem Cells to Prevent the Progression of Myopia-A Concept.

Authors:  Miroslaw Janowski; Jeff W M Bulte; James T Handa; David Rini; Piotr Walczak
Journal:  Stem Cells       Date:  2015-05-12       Impact factor: 6.277

2.  Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits.

Authors:  C Ni; L H Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

3.  Sustained release of carmustine (BCNU) for treatment of experimental intraocular malignancy.

Authors:  L H Liu; M F Refojo; C Ni; N Ueno; D M Albert
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.